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Effects of Benzo(a)pyrene on the Expression of Heat Shock 
Proteins, Pro-inflammatory Cytokines and Antioxidant Enzymes 
in Hepatic Tumors Induced by Rat Hepatoma N1-S1 Cells
Benzo(a)pyrene (BaP) is a polycyclic aromatic hydrocarbon (PAH) that is easily introduced 
to humans via consumption of grilled or smoked meat. BaP causes harmful oxidative 
effects on cell development, growth and survival through an increase in membrane lipid 
peroxidation, oxidative DNA damage and mutagenesis. Therefore, the present study was 
conducted to evaluate the synergistic effects of BaP on oxidative stress in hepatic tumors. 
In this study, we established a hepatic tumor model by injecting rat hepatoma N1-S1 cells 
into healthy rats. Changes in the abundance of heat shock proteins (HSPs), antioxidant 
enzymes and pro-inflammatory cytokines were then investigated by western blot analysis. 
In addition, we examined changes in oxidative stress levels. Injection of N1-S1 cells or 
concomitant injection of BaP and N1-S1 cells resulted in the formation of hepatic tumors 
at the injection site. Evaluation of rat plasma reveals that hepatic tumors induced by BaP 
and N1-S1 cells expresses higher levels of Hsp27, superoxide dismutase (SOD), and tumor 
necrosis factor-α (TNF-α) when compared to those induced by N1-S1 cells only. The 
collective results of this study suggest that BaP exerts synergistic effects on the expression 
of HSP, cytokines and antioxidant enzymes in hepatic tumors induced by rat hepatoma 
N1-S1 cells. 
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INTRODUCTION
Polycyclic aromatic hydrocarbons (PAHs) are common pollut-
ants found in our daily living environments. Incomplete com-
bustion of organic materials, such as residential heating, refuse 
incineration and vehicle exhausts are the major sources of PAH 
production. The International Agency for Research on Cancer 
(IARC) has characterized PAHs as carcinogens. IARC also clas-
sified Benzo(a)pyrene (BaP) as a Group 2A chemical by carci-
nogenicity (1). Metabolic activation of BaP by cytochrome P450 
enzymes leads to formation of the reactive metabolite, BaP-7,8-
diol-9,10-epoxide (BPDE). This reactive metabolite has muta-
genic and carcinogenic effects that result from its ability to react 
with DNA to form miscoding adducts, which leads to the initia-
tion of carcinogenesis (2). 
  In addition, oxidative damage induced by BaP also plays an 
important role in its carcinogenesis. BaP easily generates reac-
tive oxygen species, which in turn produce harmful oxidative 
effects against cell development, growth and survival via an in-
crease in membrane lipid peroxidation, oxidative DNA damage 
and mutagenesis (3). Further, hydroxylated radical cationic forms 
of BaP are known to be the key players involved in the BaP me-
diated tumor initiation process by leading to the formation of 
DNA adducts (4). 
  One of the factors important for the development of cancer is 
chronic inflammation (5). Pro-inflammatory cytokines such as 
tumor necrosis factor-α (TNF-α) are known to contribute not 
only to tumor promotion and progression, but also to tumor in-
vasiveness, angiogenesis, and metastasis (6). In addition, detox-
ification enzymes, particularly superoxide dismutases (SOD), 
are highly expressed in human solid tumors (7). 
  Heat shock proteins (HSPs) are chaperone proteins that pro-
tect living cells against injury-inducing stimuli. Heat shock pro-
teins derived from tumors are capable of eliciting an anticancer Zheng Z, et al.  •  Effects of Benzo(a)pyrene in Hepatic Tumors
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immune response. The expression of glucose regulating proteins 
78 (GRP78), a major endoplasmic reticulum chaperone with 
calcium binding and antiapoptotic properties, is increased in 
cancer cells, and GRP78 has been shown to promote tumor pro-
liferation, survival, and metastasis (8). In addition, Hsp90, a mo-
lecular chaperone that is responsible for helping proteins to fold 
correctly in order to achieve their functional conformation, is 
highly expressed in cancer cells (9). 
  In this study, we established a hepatic tumor animal model 
by injecting rat hepatoma N1-S1 cells into healthy Sprague-
Dawley rats. Concomitant injection of BaP induced the prolif-
eration of cancer cells and adipocytes. Histopathological chang-
es in hepatic tumors induced by N1-S1 cells and BaP, separately 
or in combination with N1-S1 cells were evaluated. Expression 
of oxidative markers such as HSPs, pro-inflammatory cytokines, 
and antioxidant enzymes were also examined to evaluate the 
synergistic effects of BaP on oxidative damage associated with 
carcinogenesis.
MATERIALS AND METHODS
Cell culture and animals
BaP, benzyl alcohol, and all other chemicals were purchased 
from Sigma Chemical Co. (St. Louis, MO, USA). Rat hepatoma 
N1-S1 cells were purchased from American Type Culture Col-
lection (ATCC, Manassas, MA, USA). N1-S1 cells were routinely 
cultured in MEM + 10% FBS, 4 mM glutamine, 50 μg/mL strep-
tomycin and 100 IU/mL penicillin G. Cells were grown at 37°C 
under a 5% CO2 atmosphere. Cells utilized for experiments were 
obtained under exponential growth conditions.
  Male Sprague-Dawley rats (173 ± 5 g) were obtained from 
Charles River Laboratories, Inc. (Wilmington, MA, USA). Rats 
were housed under standard laboratory conditions (tempera-
ture 24 ± 2°C; humidity 50 ± 10%, 12-hr day/night cycles). Prior 
to experiments, animals were allowed to acclimatize to the facil-
ity for one week, and were provided a standard chow diet and 
drinking water ad libitum. Animals were six weeks old on the 
first day of the exposure study.
Experimental design
Twenty rats (six weeks old, five per group) were divided into the 
following four groups: 1) control group (vehicle, corn oil only), 
2) BaP exposure group (200 mg/kg body weight, intraperitoneal 
injection), 3) N1-S1 group (1 × 10
7 cells injected directly into the 
liver) and 4) concomitant BaP and N1-S1 group (N1-S1 intrahe-
patic injection followed by BaP at 200 mg/kg body weight, in-
traperitoneal injection). Rats in the non-BaP-treated groups and 
non-N1-S1-treated groups were injected with either corn oil or 
culture media, respectively. After four weeks of injections, the 
rats were sacrificed and blood samples (EDTA-treated whole 
blood) were collected by cardiac puncture. Whole blood was 
centrifuged at 1,500 g at 4°C for 20 min and the resulting plasma 
was aliquoted and stored at -70°C for later analysis. This study 
was conducted from September, 2006 to December, 2008. The 
procedures for experiments and animal care were approved by 
the institutional animal care and use committee of Korea Uni-
versity (approval date: Aug. 1, 2008). 
Histological examination
Resected right hepatic lobes including tumors were sliced at a 
thickness of 3 mm, and fixed immediately in a neutral formalin 
solution, after which paraffin blocks were prepared and cut at a 
thickness of 4-6 μm. Hematoxylin and eosin staining was per-
formed for histologic evaluation.
Protein oxidation analysis
Levels of protein oxidation were evaluated by western blot anal-
ysis using an anti-dinitrophenylhydrazine antibody. Protein 
content in the plasma was first determined using the Bradford 
method, and 10 µg of total protein was then separated electro-
phoretically on a 10% polyacrylamide gel. Separated proteins 
were then transferred onto PVDF membranes using an electro-
phoretic transfer system (Amersham Biosciences, Piscataway, 
NJ, USA). Non-specific binding sites were blocked for 3 hr in 0.2% 
casein in PBS. Thereafter, the membrane was incubated for 1 hr 
with anti-dinitrophenylhydrazine antibody (1:4,000; Invitrogen, 
Carlsbad, CA, USA) in 0.2% casein. After being washed three 
times with PBS, the membrane was developed with enhanced 
chemiluminescence reagents (Amersham Biosciences). Densi-
tometry was performed using a Bio-Rad (Hercules, CA, USA) 
700 flatbed scanner with Molecular Analyst software (Bio-Rad). 
Briefly, the films and membranes were scanned at 600 dots per 
inch using light transmittance, and pixel volume analysis was 
performed on the appropriate bands.
 
Protein quantification, electrophoresis, and 
immunoblotting
Plasma collected by centrifugation of whole blood as described 
above was mixed with Laemmli sample buffer and boiled in a 
boiling water bath for 10 min. The resulting samples were then 
run on 7.5% and 12% sodium dodecyl sulfate-polyacrylamide 
gels and transferred to Immobilon membranes (Millipore, Bill-
erica, MA, USA). The following antibodies were used for immu-
nodetection: goat anti-mouse Hsp90 (1:1,000; BD Bioscience, 
San Jose, CA, USA), goat anti-rabbit GRP78 (1:600; Abcam, Cam-
bridge, UK), goat anti-rabbit Hsp27 (1:1,000; Cell Signaling, Dan-
vers, MA, USA), donkey anti-goat SOD-1 (1:1,000; Santa Cruz, 
Santa Cruz, CA, USA), goat anti-rabbit GST (1:1,000; Santa Cruz), 
donkey anti-goat TNF-α (1:1,000; Santa Cruz), donkey anti-goat 
IL-6 (1:1,000; Santa Cruz), goat anti-rabbit IL-1β (1:1,000; Santa 
Cruz), goat anti-mouse α-tubulin (1:20,000, clone DM1A; Sigma-
Aldrich). Goat anti-rabbit, goat anti-mouse, and donkey anti-Zheng Z, et al.  •  Effects of Benzo(a)pyrene in Hepatic Tumors
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goat secondary antibodies conjugated to horseradish peroxidase 
(1:2,500; Santa Cruz) followed by enhanced chemiluminescence 
reagents (Amersham Biosciences) were used to detect target 
proteins. Densitometric values were normalized using α-tubulin 
as an internal control. Scanning of the western blots showed the 
curve to be linear in the range used for each antibody.
   
Data analysis
Data in the text and figures is expressed as the mean ± SD. All 
statistic analyses were conducted using SAS version 9.1. We used 
the analysis of variance (ANOVA) method with Duncan’s and 
Tukey’s test to identify differences between the exposure and 
control groups. Differences with a P < 0.05 were considered sta-
tistically significant.
RESULTS
Establishment of a rat N1-S1 hepatic tumor model
To develop a hepatic tumor model in rats, rats in experimental 
group received liver injection of either rat hepatoma N1-S1 cells 
directly or with BaP (200 mg/kg body weight, IP) and N1-S1 cells. 
In the control group, rats were intraperitoneally injected with 
either vehicle or BaP. None of the rats injected with either vehi-
cle or BaP developed hepatic tumors. In contrast, rats injected 
with N1-S1 cells or both BaP and N1-S1 cells developed hepatic 
tumors at the injection sites (Fig. 1). Tumor sizes varied from 1.8 
mm to 8.54 mm in diameter with an average size of 8.54 ± 4.96 
mm for the N1-S1 cell injected group and 7.01 ± 3.14 mm in the 
BaP and N1-S1 cell injected group, a difference that was not sta-
tistically significant. Most of the tumors exhibited a single sharp-
ly demarcated margin with multinodular appearance (Fig. 1C), 
while two tumors from rats injected with N1-S1 cells had small 
satellite nodules (Fig. 1D). Histological findings for all tumors 
were similar (Fig. 2). Specifically, tumor cells were composed of 
large anaplastic cancer cells with variable tumoral necrosis (Fig. 
2A, B). Dystrophic calcifications were also frequently observed. 
Within all tumors, thin or thick fibrous bands were apparent 
upon examination with higher magnification. Further, the ex-
tent of tumoral necrosis was dependent on tumor sizes. Also 
observed was a small tumor 0.4 cm in diameter with tumoral 
Fig. 1. Development of tumors in rats injected with N1-S1 cells. Rats injected with N1-S1 cells were sacrificed one, two, four weeks after injection. (A) No tumors are observed 
in rats injected with vehicle controls. (B) Small tumors are found one week after injection of N1-S1 cells. (C) Tumors two weeks after injection of N1-S1 cells. A well-defined 
tumor mass with a multinodular appearance is found. (D) Tumors four weeks after injection of N1-S1 cells. The main tumor exhibits a multinodular appearance with depressed 
septations. Two satellite lesions are noted. Microscopically, all tumors revealed similar histology. 
A B
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necrotic areas, associated fibrosis, and reactive inflammation 
(Fig. 2C). Dystrophic calcifications and reactive foreign body gi-
ant cells were also frequently observed (Fig. 2D).
Expression of HSPs in N1-S1 cell-induced vs concomitant 
BaP and N1-S1 cell-induced hepatic tumors
In order to investigate the effects of BaP on the expression of oxi-
dative markers in hepatic tumors induced by rat hepatoma N1-
S1 cells, we examined changes in the abundance of HSPs, oxi-
dative stress as indicated by detoxification enzymes and protein 
oxidation, and expression levels of cytokines. First, plasma sam-
ples collected from rats that developed hepatic tumors after in-
jection of N1-S1 cells or concomitant injection of BaP and N1-
S1 cells were analyzed for changes in expression of HSPs com-
pared to vehicle-treated or BaP-treated rats by western blot anal-
ysis (Fig. 3). Vehicle-treated control rats exhibited relatively low 
expression levels of Hsp27, however, for BaP-injected rats, levels 
of Hsp27 in plasma were significantly higher than in the con-
trols. Likewise, rats with cell-induced hepatic tumors showed 
significantly higher levels of Hsp27 in plasma compared to ve-
hicle-treated controls. In rats with tumors induced by injection 
of BaP and N1-S1 cells, the levels of Hsp27 in plasma were sig-
nificantly higher compared to levels in both the vehicle-treated 
control and BaP-injected rats, as well as compared to those with 
cell-induced hepatic tumors.
  Levels of GRP78 were evaluated by western blot analysis. 
Levels of GRP78, a member of the Hsp70 family, in BaP-treated 
rats were higher than those of vehicle-treated control rats, how-
ever, this difference was not statistically significant. Conversely, 
rats that developed N1-S1 cell-induced hepatic tumors exhibit-
ed significantly higher levels of GRP78 when compared to vehi-
cle-treated controls. Levels of GRP78 in rats that developed he-
patic tumors induced by combined injection of BaP and N1-S1 
cells were also higher than in control rats, but were not signifi-
cantly different from hepatic tumors induced by injection of 
N1-S1 cells alone (Fig. 3C).
  Lastly, protein levels of Hsp90 were also investigated by west-
ern blot analysis. All experimental groups showed similar levels 
of Hsp90 and were not significantly different from each other 
(Fig. 3D).
A B
C D
Fig. 2. Histology of tumors induced by concomitant injection of BaP plus N1-S1 cells. Resected livers were fixed in formalin, and sections were stained with hematoxylin and 
eosin. (A) Most of tumors shows tumoral necrosis (H&E, × 100). (B) Tumors are composed of anaplastic round cells with pushing borders (H&E, × 200), including (C) a small     
0.4 cm diameter tumors exhibiting tumoral necrosis associated with extensive fibrosis (H&E, × 100). (D) In necrotic areas, dystrophic calcifications, fibrosis and foreign body 
type giant cell reaction are observed (H&E, × 200).Zheng Z, et al.  •  Effects of Benzo(a)pyrene in Hepatic Tumors
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Expression of antioxidant enzymes in N1-S1 cell-induced 
vs concomitant BaP and N1-S1 cell-induced hepatic tumors
The effects of BaP on the antioxidant enzymes SOD-1 and gluta-
thione S-transferase (GST) were evaluated by western blot anal-
ysis (Fig. 4A-C). BaP-injected rats showed significantly higher 
levels of SOD-1 in plasma compared to vehicle-treated controls. 
On the other hand, levels of SOD-1 in rats with cell-induced he-
patic tumors were higher than the vehicle-treated controls, al-
though the difference was not statistically significant. In contrast, 
rats with hepatic tumors induced by concomitant injection of 
BaP and N1-S1 cells had significantly higher plasma levels of 
SOD-1 than vehicle-treated controls, BaP-injected rats, and rats 
with N1-S1 cell only-induced hepatic tumors. 
  The levels of GST in the plasma of control rats were signifi-
cantly lower than in BaP-treated rats, rats with cell-induced he-
patic tumors, and rats with hepatic tumors induced by injection 
of both N1-S1 cells and BaP. However, the levels of GST in rats 
treated with BaP, rats with cell-induced hepatic tumors, or rats 
with hepatic tumors induced by injection of both BaP and N1-
S1 cells were not significantly different from one another. 
Levels of protein oxidation in N1-S1 cell-induced vs 
concomitant BaP and N1-S1 cell -induced hepatic tumors
Levels of protein oxidation were evaluated by western blot anal-
ysis using an anti-dinitrophenylhydrazine antibody (Fig. 4D, E). 
Vehicle-treated control rats exhibited relatively low levels of 
protein oxidation, but the injection of BaP only significantly in-
creased the levels of protein oxidation compared to vehicle-
treated control rats. Rats with cell-induced hepatic tumors and 
rats with hepatic tumors induced by injection of both BaP and 
N1-S1 cells also exhibited a significant increase in protein oxi-
dation compared to vehicle-treated control rats. The levels of 
protein oxidation in rats treated with BaP, rats with cell-induced 
hepatic tumors or rats with hepatic tumors induced by injection 
of both BaP and N1-S1 cells were not significantly different from 
one another.
Expression of cytokines in N1-S1 cell-induced vs 
concomitant BaP and N1-S1 cell-induced hepatic tumors
The expression levels of cytokines such as TNF-α, IL-1β and IL-6 
were evaluated by western blot analysis (Fig. 5). Plasma from 
vehicle-treated control rats showed relatively low levels of TNF- 
α. However, rats treated with BaP exhibited significantly increased 
plasma levels of TNF-α compared to vehicle-treated control rats. 
Rats with cell-induced hepatic tumors showed a significant in-
crease of TNF-α compared to vehicle-treated control rats, al-
though the difference was not significant when compared with 
BaP-injected rats. Likewise, rats with hepatic tumors induced by 
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Fig. 3. Expression levels of HSPs in rats with N1-S1 cells or concomitant injection of BaP and N1-S1 cells. Plasma collected from rats with hepatic tumors was evaluated for 
HSPs and was compared to control-injected and BaP-injected rats. (A) Western blot analysis of HSPs was performed using anti-Hsp27, Hsp90 and GRP78 antibodies. Equal 
amounts of total protein were loaded into each lane. (B-D) Graphs illustrating the changes in the levels of Hsp27, Hsp90, and GRP78 in the plasma from control-injected rats, 
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†, ‡, §, 
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injection of both BaP and N1-S1 cells showed a significant in-
crease of TNF-α in plasma compared to vehicle-treated controls, 
BaP-injected rats, and rats with cell-induced hepatic tumors.
  Treatment with BaP significantly led to a significant increase 
in the expression levels of IL-6 when compared to control rats. 
Rats that developed hepatic tumors after injection of N1-S1 cells 
also showed a significant increase in IL-6 when compared to 
controls and BaP-treated rats. Conversely, rats with hepatic tu-
mors induced by the injection of both BaP and N1-S1 cells had 
significantly increased levels of IL-6 when compared to control 
rats, but not when compared to BaP-treated rats or rats with 
N1-S1 cell-induced hepatic tumors.
  Lastly, the treatment of rats with BaP did not appear to in-
crease the levels of IL-1β in plasma. Specifically, hepatic tumors 
induced by the injection of cells or by injection of both BaP and 
N1-S1 cells did not alter the expression of IL-1β compared with 
controls.
DISCUSSION
BaP is one of PAHs that humans are primarily exposed to through 
dietary intake of grilled or smoked meat. BaP is known to cause 
harmful effects on cell development, growth and survival via an 
increase of oxidative stress. Therefore, in this study, we did not 
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investigate the carcinogenic effects of BaP, but rather the possi-
ble synergistic effects of BaP on the expression of oxidative mark-
ers in a tumor model developed by injection of rat hepatoma 
N1-S1 cells into healthy rats. Histological examination revealed 
that the incidence of hepatic tumors induced by combined in-
jection of both BaP and N1-S1 cells did not differ significantly 
when compared with tumors induced by N1-S1 cells alone. How-
ever, examination of plasma from these two groups revealed 
that there were significant increases in the levels of HSPs, anti-
oxidant enzymes, and pro-inflammatory cytokines in rats with 
hepatic tumors induced by combined injection of both BaP and 
N1-S1 cells when compared with tumors from rats injected with 
N1-S1 cells alone. 
  BaP is one of the most carcinogenic polycyclic aromatic hy-
drocarbons known. The metabolic activation of BaP by cyto-
chrome P450 isoenzymes produces a variety of mutagenic and/
or carcinogenic electrophiles. In particular, BPDE, a metabolite 
of BaP, covalently binds to DNA, RNA, and proteins. BPDE-DNA 
adducts have been shown to initiate proto-oncogenic ras (10) 
and may induce various cancers such as breast cancers (11). 
BaP-quinones are also one of the BaP-metabolites produced by 
cytochrome P450 isoenzymes. BaP-quinones are highly active 
and easily undergo one electron redox cycling resulting in the 
formation of reactive oxygen species such as the superoxide an-
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TNF-α, IL-1β and IL-6 antibodies. Equal amounts of total protein were loaded into each lane. (B-D) Graphs showing changes in the levels of TNF-α, IL-1β and IL-6 in plasma 
from controls, BaP-injected rats or rats with hepatic tumors induced by injection of N1-S1 cells or concomitant injection of BaP and N1-S1 cells. Densitometric values are 
expressed as a ratio to control rats. All data represent the mean ± SD of five different rats. P < 0.05 compared to the control rats, P < 0.05 compared to BaP-injected rats, P 
< 0.05 compared to rats with N1-S1 cell-induced hepatic tumors, P < 0.05 compared to rats with hepatic tumors induced by concomitant injection of BaP and N1-S1 cells. *, 
significantly different from control; 
†, significantly different from BaP; 
‡, significantly different from N1-S1; 
§, significantly different from N1-S1 + BaP. 
†, ‡, §
*
, ‡
ion, hydrogen peroxide, and hydroxyl radicals (12), all of which 
have been associated with cell damage and apoptosis (13). The 
DNA damage and oxidative stress induced by BaP and observed 
in this study could therefore have been due to metabolites of BaP 
such as BPDE or BaP-quinones rather than from BaP itself.
  Proteomic analysis of hepatocellular carcinomas (HCCs) col-
lected from respective patients revealed an up-regulation of 
HSPs such as Hsp27, Hsp70 and GRP78, in HCC. Further, up-
regulation of Hsp27 and GRP78 were associated with prognos-
tic values such as α-fetoprotein levels and tumor venous infil-
tration (14). In addition, Feng et al. (15) reported Hsp27 as a po-
tential biomarker for HCC as evaluated by proteome analysis. 
  Up-regulation of the HSPs described above has been associ-
ated with pro-cancer effects. Hsp27 is a member of the small 
heat-shock protein family, and its expression is increased in re-
nal cell carcinomas (16), prostate cancer (17) and ovarian can-
cer (18). Specifically, higher expression of Hsp27 is detected in 
malignant tumors compared with benign tumors in ovarian can-
cer, and is associated with advanced cancer stages and reduced 
survival rates (19). Additionally, increased expression of GRP78 
is strongly correlated with the progression of hepatocarcinogen-
esis (20). GRP78 is a member of the Hsp70 family and can be 
induced by several stimuli such as glucose starvation, hypoxia 
and endoplasmic reticulum Ca
2+ pool depletion (21). GRP78 has Zheng Z, et al.  •  Effects of Benzo(a)pyrene in Hepatic Tumors
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been tentatively implicated in the inhibition of apoptosis and 
tumor progression in mice (22). In our study, rats that developed 
hepatic tumors following combined injection of BaP and N1-S1 
cells exhibited increased expression of Hsp27 and GRP78 com-
pared to the vehicle-treated controls. In particular, Hsp27 was 
significantly increased in rats injected with both BaP and N1-S1 
cells as compared to rats with tumors induced by N1-S1 cells 
only. These results suggest that the concomitant injection of BaP 
had a synergistic effect on the development of hepatic tumors 
induced by N1-S1 cells.
  Previously, it was proposed that persistent oxidative stress 
accounts for a significant amount of the increased levels of DNA 
damage observed in cancer tissues. Immunohistochemical stud-
ies of SOD activity revealed that hepatocarcinogenesis induced 
by viral infection is closely related to the depletion of SOD in liver 
tissues (23). Further, HCC mediated by hepatitis C virus infec-
tion is associated with increased lipid peroxidation (24). Short 
term exposure to BaP has also been shown to increase lipid per-
oxidation in both serum and liver in an animal model (25). Re-
cently, it has been reported that the malignancy of HCC could 
be enhanced by increased oxidative stress through the activa-
tion of telomerase (26). In our study, the antioxidant enzymes 
SOD and GST as well as levels of protein oxidations in rats with 
hepatic tumors induced by combined injection of BaP and N1-
S1 cells were significantly higher than the vehicle-treated con-
trol rats, suggesting the involvement of oxidative stress in hepa-
tocarcinogenesis induced by the latter treatment type. However, 
BaP did not synergistically increase oxidative stress in hepatic 
tumors.
  Cancer cells may secrete various cytokines. For example, 
HepG2 cells express interferon-γ (IFN-γ), TNF-α and IL-4. Like-
wise, hepatitis-B virus-associated hepatoma cells highly express 
TGF-β2, IL-8 and monocyte chemoattactant protein-1 (27). Cy-
tokines play a role in carcinogenesis by either controlling prolif-
eration and apoptosis, or by regulating antitumor immune re-
sponse and neovascular angiogenesis (27). In addition, BaP-ex-
posed cells secrete pro-inflammatory cytokines such as IL-1β 
and IFN-γ. Increased levels of IL-6 have also been reported in 
rats exposed to BaP (28). However, conflicting results regarding 
cytokine TNF-α have been reported. Whereas treatment of pri-
mary human macrophages with BaP increases the level of TNF-α 
significantly (29), TNF-α secretion is unchanged in the murine 
macrophage cell line RAW 264.7 (30). These contradictory re-
sults may be due to species or cell type-specific differences.
  In summary, we developed a hepatic tumor animal model 
by injecting healthy rats with rat hepatoma N1-S1 cells. Injec-
tion of N1-S1 cells and concomitant injection of BaP and N1-S1 
both resulted in the formation of hepatic tumors at the injec-
tion site, and evaluation of the plasma from these two groups 
revealed significantly increased levels of HSPs such as Hsp27 
and GRP78 when compared with controls. Hsp27 in rats with 
hepatic tumors induced by concomitant injection of BaP and 
N1-S1 cells was also significantly higher than rats with hepatic 
tumors induced by the injection of N1-S1 cells alone. Similarly, 
the levels of antioxidant enzymes such as SOD and GST, as well 
as cytokines IL-6 and TNF-α were significantly higher in rats with 
hepatic tumors induced by combined injection of both BaP and 
N1-S1 cells than in control rats. The expression levels of SOD and 
TNF-α were also significantly higher in rats with hepatic tumors 
induced by combined injection of both BaP and N1-S1 cells than 
in rats with hepatic tumors induced by injection of N1-S1 cells. 
These results suggest that BaP induces synergistic effects on the 
expression of several oxidative stress markers, namely, Hsp27, 
antioxidant enzyme SOD, and cytokine TNF-α in hepatic tumors 
induced by the injection of N1-S1 cells.
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Effects of Benzo(a)pyrene on the Expression of Heat Shock Proteins, Pro-inflammatory 
Cytokines and Antioxidant Enzymes in Hepatic Tumors Induced by Rat Hepatoma 
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Benzo(a)pyrene (BaP) is a polycyclic aromatic hydrocarbon that causes harmful oxidative effects on cells through lipid peroxidation 
and oxidative DNA damage. In this study, we injected rat hepatoma N1-S1 cells into healthy rats and examined changes in heat 
shock proteins (HSP), antioxidant enzymes, pro-inflammatory cytokines and oxidative stress levels. Injection of N1-S1 cells or 
concomitant injection of BaP and N1-S1 cells resulted in the formation of hepatic tumors at the injection site. Evaluation of rat 
plasma reveals that hepatic tumors induced by BaP and N1-S1 cells expresses higher levels of Hsp27, superoxide dismutase, and 
tumor necrosis factor-α when compared to those induced by N1-S1 cells only. This study suggest that BaP exerts synergistic effects 
on the expression of HSP, cytokines and antioxidant enzymes in hepatic tumors induced by rat hepatoma N1-S1 cells. 